Last Updated on November 26, 2025 by Bilal Hasdemir
At Liv Hospital, we’re all about finding new ways to fight breast cancer in women. New treatments are giving us hope. They might help make breast cancer less likely to come back.
We know that treating breast cancer is all about you. Our team uses the latest science and treatments. We’re talking about things like camizestrant and inavolisib–palbociclib combos.
Key Takeaways
- New treatments are making survival rates better and cutting down on recurrence.
- Liv Hospital focuses on you with the latest medical care.
- Therapies like camizestrant and inavolisib–palbociclib are showing great promise.
- It’s all about tailoring treatment to you for the best results.
- Our team is here to give you the best care possible.
Understanding Breast Cancer: A Foundation for Treatment Decisions
Starting to treat breast cancer means first understanding the disease. It includes knowing its types and stages. Breast cancer is a group of diseases, not just one. They are classified by the type of cells affected, genetic characteristics, and the stage of diagnosis.
Types of Breast Cancer and Their Impact on Treatment
There are many types of breast cancer, each with its own traits and treatment needs. The most common is invasive ductal carcinoma, starting in milk ducts and spreading. Other types include invasive lobular carcinoma and triple-negative breast cancer, lacking certain proteins.
The type of breast cancer greatly affects treatment. For example, hormone receptor-positive cancers might need hormone therapy. HER2-positive cancers might get targeted therapies. Knowing the type is key to choosing the right treatment.
The Role of Staging in Treatment Planning
The stage of breast cancer is also vital for treatment planning. Staging looks at the tumor size, lymph node involvement, and metastasis. The TNM system is commonly used, focusing on tumor size, lymph node involvement, and metastasis.
Accurate staging is key for predicting outcomes and treatment. Early-stage cancers might just need surgery or surgery plus radiation. More advanced stages might need surgery, chemotherapy, targeted therapy, and hormone therapy.
- Stage I: Early-stage cancer, often treated with surgery and possibly radiation.
- Stage II and III: May require a combination of surgery, chemotherapy, radiation, and targeted therapy.
- Stage IV: Metastatic cancer, often treated with systemic therapies such as chemotherapy, hormone therapy, and targeted therapy.
Knowing the stage of breast cancer helps tailor treatment. This improves the chances of successful outcomes.
The Evolution of Breast Cancer Treatments: A Historical Perspective
The history of treating breast cancer has changed a lot. We now use more precise and personalized methods. Our understanding of the disease has grown, leading to better treatments.
From Radical Mastectomy to Precision Medicine
In the early 20th century, breast cancer treatment mainly involved radical mastectomy. This surgery removed the breast, chest muscles, and lymph nodes.
But, as time went on, we learned that less invasive surgeries could work just as well. This led to changes in how we treat breast cancer today.
The second half of the 20th century brought big improvements. Lumpectomy and radiation therapy became common. These methods help keep the breast and improve how it looks after treatment. The move to breast-conserving surgery was a big step forward. It gave patients more options and a better quality of life.
Milestones in Breast Cancer Treatment Development
Systemic therapies like chemotherapy and hormone therapy have been key. They help lower the chance of cancer coming back and improve survival. Targeted therapies have also changed the game for certain types of breast cancer, like HER2-positive.
Important milestones include:
- The introduction of sentinel lymph node biopsy, reducing the need for extensive lymph node dissection.
- The development of aromatase inhibitors for the treatment of hormone receptor-positive breast cancer.
- The approval of CDK4/6 inhibitors for advanced hormone receptor-positive breast cancer.
| Decade | Major Advances in Breast Cancer Treatment |
|---|---|
| 1940s-1950s | Radical mastectomy becomes standard practice |
| 1980s | Introduction of breast-conserving surgery and radiation therapy |
| 1990s | Development of sentinel lymph node biopsy |
| 2000s | Targeted therapies emerge, including trastuzumab for HER2-positive breast cancer |
| 2010s | CDK4/6 inhibitors approved for advanced hormone receptor-positive breast cancer |
As we keep learning more about breast cancer, the future looks bright. It’s all about precision medicine. Treatments will be made just for each patient’s cancer.
Surgical Options for Breast Cancer Treatment
Surgery is a key part of treating breast cancer. It offers many options, each suited to the patient’s needs and wishes. These choices help manage the disease effectively.
Lumpectomy vs. Mastectomy: Making the Right Choice
There are two main surgeries for breast cancer: lumpectomy and mastectomy. A lumpectomy removes the tumor and some tissue around it, aiming to keep the breast looking natural. On the other hand, a mastectomy removes the whole breast, sometimes the nipple-areola too.
Choosing between these surgeries depends on several things. These include the tumor’s size and location, the cancer’s stage, the patient’s health, and genetic factors like BRCA mutations.
Research shows that for early-stage breast cancer, lumpectomy with radiation can be as good as mastectomy. It keeps the breast and offers similar survival rates.
Reconstructive Surgery Considerations
For those having mastectomy, reconstructive surgery is key. It tries to make the breast look like it did before. This helps patients deal with the loss emotionally and physically.
There are several ways to do reconstructive surgery. These include using implants, taking tissue from the patient, or a mix of both.
When to have reconstructive surgery depends on the treatment plan and what the patient wants.
Lymph Node Surgery and Its Importance
Lymph node surgery is also vital in treating breast cancer. It removes and checks lymph nodes under the arm for cancer spread. This helps in staging the cancer and planning treatment.
There are two main types of lymph node surgery:
- Sentinel lymph node biopsy, which removes the first node cancer cells spread to
- Axillary lymph node dissection, a more thorough removal of nodes
The choice between these depends on how many nodes are involved and other factors.
Knowing about these surgical options helps patients make informed decisions. They can work with their healthcare team to pick the best treatment plan.
Radiation Therapy in Breast Cancer Management
Radiation therapy for breast cancer has become more advanced, leading to better results. It’s a key part of treatment, aiming to kill cancer cells or slow their growth. We use the latest technology to give precise doses of radiation, protecting healthy tissues.
External Beam Radiation
External Beam Radiation Therapy (EBRT) is the most common treatment for breast cancer. It uses beams from a machine outside the body to target cancer. EBRT is given daily, Monday through Friday, for weeks.
Benefits of EBRT include:
- Non-invasive procedure
- High precision in targeting cancer cells
- Ability to treat larger areas if necessary
Brachytherapy and Other Targeted Approaches
Brachytherapy places a radioactive source inside or near the tumor. It delivers high doses of radiation directly to the cancer, reducing harm to nearby tissues.
Types of Brachytherapy:
- Permanent implant: Small radioactive seeds are implanted in the breast tissue.
- Temporary implant: A catheter is placed in the breast, and radiation is delivered through it for a specific period.
Managing Side Effects of Radiation
Radiation therapy can cause side effects. We work hard to manage these to make patients more comfortable and improve their outcomes.
| Side Effect | Management Strategy |
|---|---|
| Skin Irritation | Topical creams, avoiding harsh soaps |
| Fatigue | Rest, nutrition counseling, gentle exercise |
| Lymphedema | Physical therapy, compression garments |
Understanding radiation therapy’s role in breast cancer and managing side effects helps patients make informed choices about their treatment.
Current Breast Cancer Treatments and Standard Protocols
Breast cancer treatment has made big strides, with many options for each patient. The right treatment depends on the cancer’s stage, type, and the patient’s health.
Neoadjuvant vs. Adjuvant Therapy Approaches
Neoadjuvant therapy is given before surgery to shrink tumors. This makes them easier to remove. Adjuvant therapy is given after surgery to kill any cancer cells left behind. It also lowers the chance of cancer coming back.
Neoadjuvant therapy benefits: It can make tumors operable and shows how well the tumor responds to treatment.
Adjuvant therapy benefits: It lowers the risk of cancer coming back and improves survival chances.
Common Chemotherapy Regimens
Chemotherapy uses drugs to kill cancer cells. The choice of regimen depends on the cancer type, stage, and the patient’s health. Common regimens include:
- AC (Adriamycin and cyclophosphamide) followed by T (taxotere)
- TC (taxotere and cyclophosphamide)
- FEC (fluorouracil, epirubicin, and cyclophosphamide) followed by T
| Chemotherapy Regimen | Drugs Used | Common Side Effects |
|---|---|---|
| AC-T | Adriamycin, cyclophosphamide, taxotere | Hair loss, nausea, fatigue |
| TC | Taxotere, cyclophosphamide | Hair loss, fatigue, nail changes |
| FEC-T | Fluorouracil, epirubicin, cyclophosphamide, taxotere | Hair loss, nausea, fatigue, increased risk of infection |
Treatment Selection Based on Cancer Subtype
The type of breast cancer is key in choosing the best treatment. The main types include:
- Hormone receptor-positive (HR+)
- HER2-positive (HER2+)
- Triple-negative breast cancer(TNBC)
For HR+ breast cancer, hormone therapy is often the main treatment. For HER2+ breast cancer, targeted therapies like trastuzumab are used. For TNBC, chemotherapy is usually the main treatment.
Understanding the different breast cancer subtypes and their treatments is vital for personalized care.
Hormone Therapy: Targeting Estrogen-Dependent Cancers
Hormone therapy has changed how we treat estrogen-dependent breast cancers. It works by lowering estrogen levels or blocking estrogen receptors on cancer cells. This helps slow or stop hormone receptor-positive breast cancer growth.
There are several hormone therapy types, each with its own way of working. We’ll look at three main types: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, and Selective Estrogen Receptor Degraders (SERDs).
Selective Estrogen Receptor Modulators (SERMs)
SERMs are drugs that act on estrogen receptors. They can mimic estrogen in some areas and block it in others. Tamoxifen is a well-known SERM used to treat and prevent breast cancer. It binds to estrogen receptors on breast cancer cells, stopping estrogen from promoting their growth.
- Benefits: Effective in reducing breast cancer recurrence risk and treating metastatic breast cancer.
- Side Effects: May include hot flashes, increased blood clot risk, and endometrial cancer.
Aromatase Inhibitors and Their Applications
Aromatase inhibitors are key hormone therapy drugs. They block the aromatase enzyme, which makes estrogen in postmenopausal women. This reduces estrogen levels, slowing or stopping hormone receptor-positive breast cancer growth.
Examples of aromatase inhibitors include letrozole and anastrozole. These drugs are often used in postmenopausal women and can be more effective than SERMs in this group.
| Aromatase Inhibitor | Common Use | Notable Side Effects |
|---|---|---|
| Letrozole | Adjuvant treatment for early breast cancer | Osteoporosis, hot flashes |
| Anastrozole | Treatment of advanced breast cancer | Joint pain, osteoporosis |
Selective Estrogen Receptor Degraders (SERDs)
SERDs are a newer hormone therapy class. They work by degrading estrogen receptors, reducing estrogen binding sites. Fulvestrant is a SERD used in hormone receptor-positive metastatic breast cancer treatment.
- Benefits: Can be effective in patients who have progressed on other hormone therapies.
- Administration: Typically given via injection.
In conclusion, hormone therapy is essential for treating estrogen-dependent breast cancers. By understanding SERMs, aromatase inhibitors, and SERDs, we can tailor treatments to meet individual patient needs. This improves outcomes and quality of life.
Targeted Therapies Revolutionizing Breast Cancer Care
Targeted therapies have changed how we treat breast cancer. They target specific genes in cancer cells, reducing harm to healthy cells. This leads to better treatment results.
HER2-Targeted Treatments
HER2-targeted treatments have made a big difference for HER2-positive breast cancer patients. Trastuzumab (Herceptin) was a big step forward. It has helped both early-stage and advanced HER2-positive breast cancer patients.
New treatments like ado-trastuzumab emtansine (Kadcyla) and fam-trastuzumab deruxtecan-nxki (Enhertu) have also improved care. Studies show these treatments, when used with chemotherapy, can greatly increase survival rates and lower the chance of cancer coming back.
“The introduction of HER2-targeted therapies has revolutionized the treatment of HER2-positive breast cancer, transforming what was once a poor-prognosis subtype into a potentially curable disease for many patients.”
CDK4/6 Inhibitors and Their Role
CDK4/6 inhibitors are key in treating hormone receptor-positive (HR+) HER2-negative advanced breast cancer. Drugs like palbociclib (Ibrance), ribociclib (Kisqali), and abemaciclib (Verzenio) block cell cycle progression. When used with hormone therapy, they have greatly improved survival for HR+ HER2- advanced breast cancer patients.
| CDK4/6 Inhibitor | Clinical Trial | Progression-Free Survival (PFS) Benefit |
|---|---|---|
| Palbociclib | PALOMA-2 | 24.8 months vs. 14.5 months |
| Ribociclib | MONALEESA-2 | 25.3 months vs. 16.0 months |
| Abemaciclib | MONARCH 2 | 16.4 months vs. 9.3 months |
PARP Inhibitors for BRCA-Mutated Cancers
PARP inhibitors are a big step forward for BRCA-mutated breast cancers. Olaparib (Lynparza) and talazoparib (Talzenna) have shown great results in patients with BRCA1/2 mutations and HER2-negative metastatic breast cancer. They work by blocking DNA repair, which is a weakness in BRCA-mutated cancers.
For more info on breast cancer by age and treatment, check out Liv Hospital’s resource on breast cancer age.
As we learn more about breast cancer, targeted therapies will keep leading the way in treatment. They offer new hopes for better patient outcomes.
Emerging Combination Therapies for Advanced Breast Cancer
Research in breast cancer is moving forward, bringing new hope for those with advanced disease. The complex nature of breast cancer calls for a multi-faceted treatment approach. Combination therapies are leading the way in this effort.
Inavolisib and Palbociclib for PIK3CA-Mutated Cancers
Studies show promise in combining inavolisib with palbociclib for PIK3CA-mutated advanced breast cancer. Inavolisib targets the PI3K pathway, often disrupted in breast cancer. Paired with palbociclib, a CDK4/6 inhibitor, this combo has shown great results in extending progression-free survival.
Key Benefits of Inavolisib and Palbociclib Combination:
- Enhanced efficacy in PIK3CA-mutated cancers
- Improved progression-free survival rates
- Potential for better overall survival outcomes
SERD and CDK4/6 Inhibitor Combinations
Combining Selective Estrogen Receptor Degraders (SERDs) with CDK4/6 inhibitors is another promising strategy. This combo targets hormone receptor-positive breast cancer cells. It aims to overcome resistance to endocrine therapy.
| Therapy Combination | Target Population | Key Benefits |
|---|---|---|
| SERD + CDK4/6 Inhibitor | Hormone receptor-positive breast cancer | Overcomes endocrine resistance, improves PFS |
| Inavolisib + Palbociclib | PIK3CA-mutated advanced breast cancer | Targets PI3K pathway, enhances efficacy |
Overcoming Treatment Resistance Through Combination Approaches
Treatment resistance is a big challenge in managing advanced breast cancer. Combination therapies aim to tackle this by targeting multiple pathways at once. By understanding and overcoming resistance, we can improve outcomes for patients with advanced disease.
The future of breast cancer treatment is in tailoring therapies to each patient. Using combination approaches can maximize effectiveness and reduce resistance.
Immunotherapy: The Frontier of Breast Cancer Treatments
Immunotherapy is a new and promising way to fight breast cancer. It uses the body’s immune system to find and destroy cancer cells. This method is showing great promise, mainly for aggressive and hard-to-treat types of breast cancer.
Checkpoint Inhibitors in Triple-Negative Breast Cancer
Checkpoint inhibitors are a big deal in breast cancer treatment. They help the immune system fight cancer cells better. In triple-negative breast cancer, these drugs have shown great results. They work best when used with chemotherapy.
Key benefits of checkpoint inhibitors in TNBC include:
- Increased overall survival rates
- Improved response rates compared to traditional chemotherapy
- Potential for durable responses, with some patients experiencing long-term remission
Vaccine Development for Breast Cancer
Vaccine research is also making strides in breast cancer treatment. Therapeutic vaccines aim to treat existing cancer by boosting the immune system. They target specific proteins found in cancer cells.
The advantages of breast cancer vaccines include:
- Targeted treatment with potentially fewer side effects
- Possibility of combining vaccines with other therapies for enhanced effectiveness
- Potential for long-term immune memory, reducing the risk of recurrence
Future Directions in Breast Cancer Immunotherapy
Research in breast cancer immunotherapy is moving towards more personalized treatments. We’re seeing a focus on using immunotherapy earlier and combining it with other treatments. There’s also a push to find biomarkers to see who will benefit most.
Emerging trends in breast cancer immunotherapy include:
- Combination regimens that pair immunotherapy with targeted therapies or chemotherapy
- Development of neoantigen-based therapies tailored to individual patients’ tumors
- Increased focus on understanding and overcoming resistance to immunotherapy
Immunotherapy is becoming a key part of breast cancer treatment. By investing in research and trials, we can make these treatments even better. This will help improve outcomes for patients all over the world.
Personalized Medicine: Tailoring Breast Cancer Therapy Options
We are seeing a big change in how we treat breast cancer. Now, we tailor treatments to each patient. This makes treatments work better and cuts down on side effects.
Personalized medicine in breast cancer uses new technologies. Genomic assays, liquid biopsies, and AI are key. They help decide the best treatment for each patient.
Genomic Assays for Treatment Decision-Making
Genomic assays have changed how we treat breast cancer. They look at a tumor’s genes. This helps predict if cancer will come back and if chemo will help.
- Oncotype DX: A well-known assay that gives a score for early-stage breast cancer. It helps decide treatment.
- MammaPrint: It sorts patients into high or low risk for cancer coming back. This helps plan treatment.
Liquid Biopsies and Circulating Tumor DNA
Liquid biopsies are a new way to check on cancer. They look at DNA in the blood. This lets doctors see if the cancer is changing.
This method helps doctors adjust treatments quickly. It makes treatments more effective.
AI and Machine Learning in Treatment Selection
AI and machine learning are being used more in treating cancer. They look at lots of data to find patterns. This helps doctors pick the best treatments for each patient.
- AI looks at data like genes, medical history, and treatment results. It helps plan treatments.
- Machine learning finds the best combinations of treatments. It also predicts if treatments will work.
By using these new technologies, we can treat breast cancer better. This improves how patients feel and live.
Liv Hospital’s Approach to Innovative Breast Cancer Solutions
Liv Hospital focuses on academic excellence and patient care. We aim to offer the latest and most effective breast cancer treatments.
Academic Protocols and Quality Standards
At Liv Hospital, we follow strict academic protocols for top-notch care. Our treatments are based on the latest research and guidelines. This ensures our patients get the best care possible.
We also work hard to improve patient outcomes. This shows our dedication to quality care.
Access to Emerging Therapies and Clinical Trials
Liv Hospital is a leader in emerging therapies and clinical trials for breast cancer. We give our patients access to new treatments. This gives them a chance to try the latest medicine.
Our team stays up-to-date with international research. This ensures our patients get the newest and most innovative therapies.
Comprehensive Care for Breast Cancer Patients
We know breast cancer treatment is more than just medicine. At Liv Hospital, we offer comprehensive support. This includes psychological counseling, nutritional guidance, and rehabilitation services.
Our team works together to meet each patient’s needs. We ensure they get holistic care from start to finish.
Conclusion: The Quest for a Breast Cancer Cure Continues
Breast cancer treatment has made big strides, giving hope to people all over the world. Studies like the one on PRS313 show the ongoing research in breast cancer. They help doctors tailor treatments better.
New treatments and therapies are on the horizon. This includes personalized medicine and new combinations of treatments. Yet, finding a cure for breast cancer is a big challenge we face.
Our search for a cure is fueled by ongoing research and new treatments. This ensures patients get the best care. Moving forward, using new technologies and approaches will be key in treating breast cancer.
FAQ
What are the different types of breast cancer treatments available?
We offer many treatments, like surgery and radiation therapy. We also have chemotherapy, hormone therapy, and targeted therapies. Each treatment is chosen based on the patient’s needs and cancer type.
How is breast cancer staging important in treatment planning?
Staging shows how far the cancer has spread. It’s key for planning the best treatment. It also helps predict how well the patient will do.
What is the role of lumpectomy and mastectomy in breast cancer treatment?
Lumpectomy and mastectomy are surgical options. We consider the tumor size, location, and patient preference. This helps decide which procedure is best.
How does radiation therapy work in breast cancer management?
Radiation therapy kills cancer cells with high-energy rays. We use external beam radiation and brachytherapy. These methods target the tumor while protecting healthy tissue.
What is the significance of hormone therapy in treating estrogen-dependent breast cancers?
Hormone therapy is for estrogen receptor-positive breast cancers. It blocks estrogen’s effects on cancer cells. This slows or stops tumor growth.
How do targeted therapies work in breast cancer treatment?
Targeted therapies target cancer cells or proteins that help cancer grow. They reduce harm to healthy cells. Examples include HER2-targeted treatments and CDK4/6 inhibitors.
What are the emerging combination therapies for advanced breast cancer?
We’re exploring new combination therapies. These include inavolisib and palbociclib, and SERD and CDK4/6 inhibitor combinations. They aim to overcome treatment resistance and improve outcomes.
How is immunotherapy being used in breast cancer treatment?
Immunotherapy is being studied for breast cancer. It includes checkpoint inhibitors and vaccine development. It aims to boost the body’s immune response against cancer cells.
What is personalized medicine, and how is it applied in breast cancer treatment?
Personalized medicine tailors treatment to the individual. It considers their genetic profile, medical history, and other factors. We use genomic assays, liquid biopsies, and AI to guide treatment decisions.
What is Liv Hospital’s approach to breast cancer treatment?
At Liv Hospital, we focus on innovative, personalized care for breast cancer patients. We offer access to new therapies and clinical trials. Our goal is to provide quality care and advance treatment options.
Is there a cure for breast cancer?
We’ve made great progress in treating breast cancer, but finding a cure is ongoing. We continue to learn more about the disease. Our goal is to develop new treatments to improve patient outcomes.
How can I find the most effective treatment for my breast cancer?
We recommend talking to our team to find the best treatment for you. We consider your individual needs, cancer subtype, and medical history. This helps us determine the most effective plan.
FAQ
What are the different types of breast cancer treatments available?
We offer many treatments, like surgery and radiation therapy. We also have chemotherapy, hormone therapy, and targeted therapies. Each treatment is chosen based on the patient’s needs and cancer type.
How is breast cancer staging important in treatment planning?
Staging shows how far the cancer has spread. It’s key for planning the best treatment. It also helps predict how well the patient will do.
What is the role of lumpectomy and mastectomy in breast cancer treatment?
Lumpectomy and mastectomy are surgical options. We consider the tumor size, location, and patient preference. This helps decide which procedure is best.
How does radiation therapy work in breast cancer management?
Radiation therapy kills cancer cells with high-energy rays. We use external beam radiation and brachytherapy. These methods target the tumor while protecting healthy tissue.
What is the significance of hormone therapy in treating estrogen-dependent breast cancers?
Hormone therapy is for estrogen receptor-positive breast cancers. It blocks estrogen’s effects on cancer cells. This slows or stops tumor growth.
How do targeted therapies work in breast cancer treatment?
Targeted therapies target cancer cells or proteins that help cancer grow. They reduce harm to healthy cells. Examples include HER2-targeted treatments and CDK4/6 inhibitors.
What are the emerging combination therapies for advanced breast cancer?
We’re exploring new combination therapies. These include inavolisib and palbociclib, and SERD and CDK4/6 inhibitor combinations. They aim to overcome treatment resistance and improve outcomes.
How is immunotherapy being used in breast cancer treatment?
Immunotherapy is being studied for breast cancer. It includes checkpoint inhibitors and vaccine development. It aims to boost the body’s immune response against cancer cells.
What is personalized medicine, and how is it applied in breast cancer treatment?
Personalized medicine tailors treatment to the individual. It considers their genetic profile, medical history, and other factors. We use genomic assays, liquid biopsies, and AI to guide treatment decisions.
What is Liv Hospital’s approach to breast cancer treatment?
At Liv Hospital, we focus on innovative, personalized care for breast cancer patients. We offer access to new therapies and clinical trials. Our goal is to provide quality care and advance treatment options.
Is there a cure for breast cancer?
We’ve made great progress in treating breast cancer, but finding a cure is ongoing. We continue to learn more about the disease. Our goal is to develop new treatments to improve patient outcomes.
How can I find the most effective treatment for my breast cancer?
We recommend talking to our team to find the best treatment for you. We consider your individual needs, cancer subtype, and medical history. This helps us determine the most effective plan.
- Labiotech. Future breast cancer treatment. https://www.labiotech.eu/in-depth/future-breast-cancer-treatment/
- Institute of Cancer Research (ICR). ASCO 2025: New therapy improves survival in advanced breast cancer and delays need for chemotherapy. https://www.icr.ac.uk/about-us/icr-news/detail/asco-2025–new-therapy-improves-survival-in-advanced-breast-cancer-and-delays-need-for-chemotherapy
- Living Beyond Breast Cancer (LBBC). New breast cancer drugs and treatment combinations show promise across subtypes: ASCO 2025. https://www.lbbc.org/news/new-breast-cancer-drugs-and-treatment-combinations-show-promise-across-subtypes-asco-2025
- Breast Cancer Research Foundation (BCRF). ASCO 2025 metastatic breast cancer updates. https://www.bcrf.org/blog/asco-2025-metastatic-breast-cancer-updates/
